TBK1 and prostate carcinoma: In prostate cancer Docetaxel-resistant cells, low expression of LINC01085 enhances TBK1 interaction with GSK3β and accelerates phosphorylation of TBK1 at Ser-172, thereby increasing expression of PD-L1 and NF-κB (60).